NA
PHAR

NewEdge Advisors’s Pharming Group PHAR Stock Holding History

NewEdge Advisors’s Portfolio PHAR Stock Details PHAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.6K Sell
187
-1,963
-91% -$28.4K ﹤0.01% 3868
2026
Q1 		$35.8K Sell
2,150
-26,718
-93% -$453K ﹤0.01% 3031
2025
Q4 		$510K Buy
28,868
+28,615
+11,310% +$450K ﹤0.01% 1949
2025
Q3 		$3.67K Buy
+253
New +$3.15K ﹤0.01% 3621

Other funds holding PHAR

MACM
MAC Alpha Capital Management Tampa, Florida $216M AUM
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $309M AUM
KCM
Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return
SGFG
Silver Grove Financial Group Orchard Park, New York $185M AUM 28.01% 1-Year Est. Return
NSG
Nalls Sherbakoff Group Knoxville, Tennessee $141M AUM 25.05% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM

NewEdge Advisors's PHAR Position: Q2 2026 in Review

NewEdge Advisors reduced its Pharming Group (PHAR) stake by 91% in Q2 2026, selling an estimated $28.4K and leaving 187 shares worth $2.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3868.

NewEdge Advisors first reported a position in PHAR in Q3 2025 and has held it in 4 quarters since. The position peaked at $510K in Q4 2025. 17 funds tracked by Wall St. Rank hold PHAR as of Q2 2026.

  • NewEdge Advisors held 187 shares of Pharming Group worth $2.6K as of Q2 2026.
  • NewEdge Advisors sold 1,963 Pharming Group shares in Q2 2026, an estimated $28.4K.
  • Pharming Group made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #3868 holding.
  • NewEdge Advisors first reported a position in Pharming Group in Q3 2025 and has held it in 4 quarters since.
  • NewEdge Advisors's Pharming Group position peaked at $510K in Q4 2025.
  • 17 funds tracked by Wall St. Rank held Pharming Group as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.